As type 2 diabetes (T2D) continues to rise globally and nationally, Thailand has taken decisive action to strengthen comprehensive diabetes care and support people at highest risk. Since 2022, a multidisciplinary network bringing together the Ministry of Public Health, national professional associations, academic experts and supported by the WHO Country Cooperation Strategy (CCS) NCDs Programme, has developed a national guideline for T2D remission anchored in intensive lifestyle modification.
This new guideline provides a practical, evidence-informed framework for health-care providers, complementing Thailand’s existing diabetes care services and enabling earlier, more holistic intervention for individuals newly diagnosed with T2D. The programme aims not only to improve metabolic outcomes, but to empower people with sustainable, healthy behaviours that can transform long‑term health trajectories.
Now officially adopted as MOPH policy, the Diabetes Remission Programme is being implemented across multiple health facilities nationwide. Documentation of best practices, clinical outcomes and cost‑effectiveness is underway, supporting Thailand’s goal to scale up the programme and integrate remission-focused care across routine health services.
On 26 February 2026, Thailand’s case study on diabetes remission was featured on the WHO Knowledge Action Portal on NCDs—highlighting the country’s leadership and providing inspiration for other countries seeking people-centred and prevention-driven solutions to the growing diabetes burden.
Read the full case story on the WHO Knowledge Action Portal: Strengthening comprehensive diabetes care with innovative approaches: Thailand’s National Diabetes Remission Programme